MedTrace Logo

Prioritising and Optimising Multi-medication in Multimorbidity

NCT01171339 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 505

Last updated 2017-10-31

No results posted yet for this study

Summary

Objective: To investigate whether the complex intervention will improve the appropriateness of prescriptions in elderly multi-morbid patients with multi-medication in general practices.

Study hypothesis: The primary objective of the study is to determine whether the complex intervention will improve the appropriateness of prescriptions compared to usual care. The primary efficacy endpoint is the change in the Medication Appropriateness Index (MAI) score from baseline (T0) to 6 months after baseline (T1), i.e. the difference MAI T1-T0.

Conditions

Interventions

OTHER

Optimization strategy (complex intervention)

Healthcare assistant (HCA) and computer assisted optimization of multi-medication (complex intervention) in accordance with recommended standard# #Recommended standard: clinical practice guideline "Geriatrie" of the guideline group of Hesse (part 1 and 2)

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • Johann Wolfgang Goethe University Hospital

    collaborator OTHER

  • University Hospital Heidelberg

    collaborator OTHER

  • Heidelberg University

    collaborator OTHER

  • Maastricht University Medical Center

    collaborator OTHER

  • University of Oxford

    collaborator OTHER

  • Goethe University

    lead OTHER

Principal Investigators

  • Christiane Muth, MD, MPH · Institute for General Practice, Goethe-University Frankfurt / Main

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-01
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01171339 on ClinicalTrials.gov